Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine during therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy
PACTR202006515915908Completed
- Sponsor
- South African Medical Research Council
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of morphine in hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by South African Medical Research Council. Primary endpoints: Survival to 18 months and Survival without major disability at 18 months. Started Jul 2011; status: completed.
02
Drugs
morphine
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on PACTR202006515915908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006515915908.